citalopram has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergmeier, W; Bonna, AM; Cook, AA; Jarvis, GE; Jung, SM; Moroi, M; Roweth, HG; Sage, SO | 1 |
1 other study(ies) available for citalopram and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
Article | Year |
---|---|
Two novel, putative mechanisms of action for citalopram-induced platelet inhibition.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Calcium; Citalopram; Cytosol; Humans; L-Lactate Dehydrogenase; Models, Biological; Neutrophils; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins | 2018 |